US approves monkeypox detection test, Swiss giant Roche says
The US drugs agency has approved a test by Swiss pharmaceutical giant Roche that can detect monkeypox, the company said on Wednesday.
Nov 16, 2022
0
4
The US drugs agency has approved a test by Swiss pharmaceutical giant Roche that can detect monkeypox, the company said on Wednesday.
Nov 16, 2022
0
4
Swiss pharmaceutical giant Roche said Wednesday it had come up with PCR tests that can detect monkeypox, as the virus spreads outside endemic countries.
May 25, 2022
0
79
The U.S. Medicare program's decision to tightly limit coverage for the first drug meant to slow the course of Alzheimer's disease has raised the stakes for companies trying to make the next one.
Apr 11, 2022
0
2
Swiss pharma giant Roche announced Tuesday promising results from clinical trials of an anti-COVID cocktail developed with US biotech firm Regeneron.
Mar 23, 2021
0
24
Swiss pharma giant Roche announced Tuesday the launch of a new test to help researchers find coronavirus variants which are feared to be more harmful or could undermine vaccines.
Mar 16, 2021
0
7
Swiss pharmaceuticals giant Roche said Thursday it is collaborating with Atea Pharmaceuticals on the development of an orally administered drug to treat coronavirus patients who have not been hospitalised.
Oct 22, 2020
0
4
The French competition authority (AFC) on Thursday slapped a record 444 million euro ($500 million) fine on pharma groups Novartis, Roche and Genentech over market abuses in sales of macular degeneration drugs.
Sep 9, 2020
0
3
Swiss pharmaceuticals giant Roche said Friday it had received the green light in the United States for emergency use of a diagnostic test differentiating between coronavirus and influenza.
Sep 4, 2020
0
1
Swiss pharmaceuticals giant Roche joined forces Wednesday with Regeneron to scale up supply of the US firm's REGN-COV2 medicine—potentially both a prevention and treatment for COVID-19 infection.
Aug 19, 2020
0
8
Swiss pharmaceuticals giant Roche said Thursday the US authorities had given it emergency clearance for a test identifying patients most at risk of a dangerous immune response to coronavirus infection.
Jun 4, 2020
0
1